Crawford Healthcare US entry through partnership with Exciton
Crawford Healthcare accelerates entry into US market through partnership with Exciton Technologies
Crawford Healthcare has signed a long-term partnership agreement with Exciton Technologies, a Canadian technology company, to exclusively licence their patented Exsalt® antimicrobial woundcare technology.
Knutsford-based Crawford Healthcare will take over the existing Exciton operations in the US, including its salesforce, to complement Crawford’s own recently opened US entity. The healthcare supplier has also secured the initial rights for most of Europe, Russia and CIS along with other territories, with the option to gain worldwide rights.
